1. Home
  2. CMPR vs FTRE Comparison

CMPR vs FTRE Comparison

Compare CMPR & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CMPR
  • FTRE
  • Stock Information
  • Founded
  • CMPR 1994
  • FTRE 1996
  • Country
  • CMPR Ireland
  • FTRE United States
  • Employees
  • CMPR N/A
  • FTRE N/A
  • Industry
  • CMPR Publishing
  • FTRE Medical Specialities
  • Sector
  • CMPR Consumer Discretionary
  • FTRE Health Care
  • Exchange
  • CMPR Nasdaq
  • FTRE Nasdaq
  • Market Cap
  • CMPR 2.0B
  • FTRE 1.7B
  • IPO Year
  • CMPR N/A
  • FTRE N/A
  • Fundamental
  • Price
  • CMPR $81.25
  • FTRE $19.50
  • Analyst Decision
  • CMPR Strong Buy
  • FTRE Hold
  • Analyst Count
  • CMPR 2
  • FTRE 11
  • Target Price
  • CMPR $114.50
  • FTRE $24.50
  • AVG Volume (30 Days)
  • CMPR 160.8K
  • FTRE 1.4M
  • Earning Date
  • CMPR 10-30-2024
  • FTRE 11-08-2024
  • Dividend Yield
  • CMPR N/A
  • FTRE N/A
  • EPS Growth
  • CMPR N/A
  • FTRE N/A
  • EPS
  • CMPR 5.90
  • FTRE N/A
  • Revenue
  • CMPR $3,339,531,000.00
  • FTRE $2,975,600,000.00
  • Revenue This Year
  • CMPR $7.63
  • FTRE N/A
  • Revenue Next Year
  • CMPR $5.45
  • FTRE $0.44
  • P/E Ratio
  • CMPR $13.51
  • FTRE N/A
  • Revenue Growth
  • CMPR 6.57
  • FTRE 2.80
  • 52 Week Low
  • CMPR $58.05
  • FTRE $16.53
  • 52 Week High
  • CMPR $104.92
  • FTRE $41.02
  • Technical
  • Relative Strength Index (RSI)
  • CMPR 55.54
  • FTRE 50.78
  • Support Level
  • CMPR $75.55
  • FTRE $18.29
  • Resistance Level
  • CMPR $83.04
  • FTRE $25.28
  • Average True Range (ATR)
  • CMPR 3.04
  • FTRE 1.20
  • MACD
  • CMPR 0.39
  • FTRE 0.01
  • Stochastic Oscillator
  • CMPR 84.67
  • FTRE 33.56

About CMPR Cimpress plc (Ireland)

Cimpress PLC invests in and builds customer-focused, entrepreneurial, mass-customization businesses for the long term. Mass customization seeks to produce goods and services to meet individual customer needs with near mass production efficiency. Its products and services include a broad range of marketing materials, business cards, signage, promotional products, logo apparel, packaging, books and magazines, wall decor, photo merchandise, invitations and announcements, design and digital marketing services, and other categories. The company's segment includes Vista; PrintBrothers; The Print Group; National Pen and All Other Businesses. It generates maximum revenue from the Vista segment.

About FTRE Fortrea Holdings Inc.

Fortrea Holdings is a late-stage contract research organization, or CRO, that provides comprehensive Phase I through IV clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

Share on Social Networks: